<ѻýҕl>Checkpoint Inhibitors Whiff in Head and Neck Cancer Trialsѻýҕl> Avelumab, nivolumab-ipilimumab, pembrolizumab miss endpoints in separate studies Sep 23, 2021
<ѻýҕl>Top Science From the World Conference on Lung Cancerѻýҕl> In this podcast, we examine some of the most important studies presented at this year's meeting Sep 23, 2021 podcast
<ѻýҕl>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻýҕl> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻýҕl>Study Finds More Later-Stage CRC Diagnoses During Pandemicѻýҕl> Japanese registry data reveals increase in stage III colorectal cancer, drops in earlier disease Sep 22, 2021
<ѻýҕl>Survey Says: Support Is Lacking for Cancer's Lingering Effectsѻýҕl> Survivors report dissatisfaction with long-term support Sep 22, 2021
<ѻýҕl>Angiogenesis Inhibitor Slows Extrapancreatic Neuroendocrine Tumorsѻýҕl> Almost 7-month increase in median PFS with addition of axitinib to endocrine therapy Sep 21, 2021
<ѻýҕl>Transarterial Radioembolization Slows Progression of CRC With Liver Metsѻýҕl> Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
<ѻýҕl>Androgen-Targeting Combos Show Promise in Prostate Cancerѻýҕl> Trials extend survival in hormone-sensitive disease Sep 21, 2021
<ѻýҕl>Bifunctional Protein Shows Promise in HPV-Related Cancersѻýҕl> Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
<ѻýҕl>Sunitinib Effective in Very Rare Neuroendocrine Tumorѻýҕl> The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
<ѻýҕl>Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBCѻýҕl> KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
<ѻýҕl>ADC Makes a Case for Role in Metastatic HER2-Positive Breast Cancerѻýҕl> Improved progression-free survival in previously treated disease with trastuzumab duocarmazine Sep 20, 2021
<ѻýҕl>Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancerѻýҕl> MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
<ѻýҕl>Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancerѻýҕl> More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
<ѻýҕl>Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanomaѻýҕl> Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
<ѻýҕl>Practice-Changing Study in Advanced Cervical Cancerѻýҕl> Improved PFS, OS with pembrolizumab and chemo with or without bevacizumab Sep 18, 2021
<ѻýҕl>Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer?ѻýҕl> DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
<ѻýҕl>Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancerѻýҕl> 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
<ѻýҕl>As Safety Data on HPV Vaccine Improves, Why Is Parental Hesitancy Going Up?ѻýҕl> Findings suggest "an urgent need" to combat sentiment, restore confidence, researchers say Sep 17, 2021
<ѻýҕl>Rechallenge With PARP Inhibitor Slows Relapsed Ovarian Cancerѻýҕl> Benefits platinum-sensitive disease irrespective of BRCA, homologous repair status, study showed Sep 17, 2021
<ѻýҕl>Some Reassurance on Cancer Risk With RAI Therapy for Hyperthyroidismѻýҕl> No overall risk increase in large meta-analysis, but higher risk seen for thyroid cancer Sep 17, 2021
<ѻýҕl>Longer Hydroxyurea Tied to Improved Sickle-Cell Heart Issuesѻýҕl> Kids on treatment for less than 1 year had a significantly greater prevalence of LV dilation Sep 16, 2021
<ѻýҕl>AI's Help in Colonoscopy Led to Fewer Missed Adenomasѻýҕl> U.S. study explores benefit of newer technology in colon cancer screening, surveillance Sep 15, 2021
<ѻýҕl>More Help on the Way for Lung Cancers With Exon 20 Mutations?ѻýҕl> Early trials of DZD9008 demonstrated responses in over a third of patients Sep 15, 2021
<ѻýҕl>Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancerѻýҕl> More than 90% disease control rate, hint of improved PFS in pilot trial Sep 14, 2021
<ѻýҕl>Novel ADC Promising in Certain Non-Squamous Lung Cancersѻýҕl> Response rate topped 50% in patients with EGFR wild-type tumors and high MET expression Sep 14, 2021
<ѻýҕl>Stanley Tucci's Tongue Cancerѻýҕl> The Oscar-nominated actor opens up about his private battle Sep 13, 2021
<ѻýҕl>More Data in Support of Surgery for Malignant Pleural Mesotheliomaѻýҕl> Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
<ѻýҕl>Meta-Analysis Confirms Benefits of Low-Dose CT Screening for Lung Cancerѻýҕl> LDCT associated with a 16% relative reduction in mortality versus no screening Sep 13, 2021
<ѻýҕl>Best Way to Recover Urinary Continence After Prostatectomy?ѻýҕl> Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
<ѻýҕl>Which Prostate Biopsy Is Best: Transrectal or Transperineal?ѻýҕl> Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
<ѻýҕl>Immuno-Oncology Combo Active in Recurrent EGFR/ALK Positive NSCLCѻýҕl> Responses in 42% of EGFR group, limited activity in ALK-rearranged lung cancer Sep 12, 2021
<ѻýҕl>Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesotheliomaѻýҕl> Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
<ѻýҕl>Plant-Based Diet Tied to Better Urological Health in Menѻýҕl> "Eat more plants for your prostate and your erections Sep 12, 2021
<ѻýҕl>Durable Response with Immunotherapy Combos in NSCLC with Brain Metastasesѻýҕl> Analysis of CheckMate 9LA data and phase II study from Spain offer hope in advanced disease Sep 12, 2021
<ѻýҕl>Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancerѻýҕl> Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
<ѻýҕl>9/11 Responders Face Higher Risk of Multiple Cancersѻýҕl> Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
<ѻýҕl>Durable Responses With IL-15 Superagonist in Early Bladder Cancerѻýҕl> Addition of N-803 led to better responses in BCG-unresponsive disease Sep 10, 2021
<ѻýҕl>Dual Immunotherapy Boosts Survival in Metastatic NSCLCѻýҕl> Benefit with durvalumab-tremelimumab may vary by PD-L1 expression, histology Sep 10, 2021
<ѻýҕl>Cancer Patients, COVID-19, and Long-Term Effectsѻýҕl> Preventing COVID sequelae can minimize disruption of cancer care, European study finds Sep 09, 2021